Deep TMS: Final clinical trial data

Final data from a double-blind, Israeli trial in 25 patients with OCD who failed to respond to both pharmacological and psychological therapy showed that high-frequency Deep TMS led to a significant mean improvement of 27% in the severity of OCD symptoms as measured by Y-BOCS scores vs. a 0% improvement for sham control (p=0.0003). Low-frequency Deep TMS led to a non-significant mean improvement of 13% on the endpoint. Brainsway previously reported interim data from 9 evaluable patients (see BioCentury, July 9, 2012). Brainsway said it plans to conduct a pivotal trial evaluating Deep TMS to treat OCD, but declined to disclose details. ...